Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 Apr 1;183(4):1427-36.
doi: 10.1084/jem.183.4.1427.

Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone

Affiliations

Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone

L P Shornick et al. J Exp Med. .

Abstract

Mice rendered deficient in IL-1 beta by gene targeting in embryonic stem cells develop and grow normally in a protected laboratory environment. Endotoxin-stimulated peritoneal macrophages from IL-1beta-deficient mice showed normal synthesis and cellular release of IL-1alpha after treatment with 5 mM ATP demonstrating that IL-1beta is not necessary for expression and release of the IL-1alpha isoform. Mice deficient in IL-1beta showed unaltered sensitivity to endotoxic shock, with or without pretreatment with D-galactosamine. In contrast, IL-1beta-deficient mice showed defective contact hypersensitivity responses to topically applied trinitrochlorobenzene (TNCB). This defect could be overcome either by application of very high doses of sensitizing antigen, or by local intradermal injection of recombinant IL-1beta immediately before antigen application. These data demonstrate an essential role for IL-1beta in contact hypersensitivity and suggest that IL-1beta acts early during the sensitization phase of response. They suggest an important role for IL-1beta in initiation of the host of response at the epidermal barrier.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Nature. 1990 Jan 25;343(6256):341-6 - PubMed
    1. J Immunol. 1992 Nov 15;149(10):3254-9 - PubMed
    1. J Immunol. 1993 May 1;150(9):3698-704 - PubMed
    1. Nature. 1993 Aug 26;364(6440):798-802 - PubMed
    1. Clin Exp Rheumatol. 1993 Sep-Oct;11(5):515-22 - PubMed

Publication types